GEMCITABINE - CURRENT STATUS OF PHASE-I AND PHASE-II TRIALS

被引:204
作者
KAYE, SB
机构
关键词
D O I
10.1200/JCO.1994.12.8.1527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1527 / 1531
页数:5
相关论文
共 46 条
[11]  
CASPER ES, IN PRESS INVEST NEW
[12]   PHASE-II STUDY OF TAXOL, MERBARONE, AND PIROXANTRONE IN STAGE-IV NON-SMALL-CELL LUNG-CANCER - THE EASTERN COOPERATIVE ONCOLOGY GROUP RESULTS [J].
CHANG, AY ;
KIM, K ;
GLICK, J ;
ANDERSON, T ;
KARP, D ;
JOHNSON, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :388-394
[13]  
CLAVEL M, 1992, P AN M AM SOC CLIN, V11, P249
[14]  
CLAVEL M D, 1989, Investigational New Drugs, V7, P379
[15]   GEMCITABINE IS AN ACTIVE NEW AGENT IN PREVIOUSLY UNTREATED EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC) - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP [J].
CORMIER, Y ;
EISENHAUER, E ;
MULDAL, A ;
GREGG, R ;
AYOUB, J ;
GOSS, G ;
STEWART, D ;
TARASOFF, P ;
WONG, D .
ANNALS OF ONCOLOGY, 1994, 5 (03) :283-285
[16]  
CORMIER Y, 1994, P AN M AM SOC CLIN, V13, P1140
[17]   A PHASE-II STUDY OF NAVELBINE (VINORELBINE) IN THE TREATMENT OF NON SMALL-CELL LUNG-CANCER [J].
DEPIERRE, A ;
LEMARIE, E ;
DABOUIS, G ;
GARNIER, G ;
JACOULET, P ;
DALPHIN, JC .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (02) :115-119
[18]  
DUNLOP DJ, 1994, P AN M AM SOC CLIN, V13, P342
[19]  
FINK U, 1992, P AM SOC CLIN ONCOL, V11, P507
[20]  
FOSELLA F, 1993, EUR J CANC S6, V29, pS119